IDEXX Laboratories Inc (IDXX)
Debt-to-equity ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 622,883 | 694,387 | 775,205 | 858,492 | 698,910 |
Total stockholders’ equity | US$ in thousands | 1,484,530 | 608,737 | 689,992 | 632,088 | 177,473 |
Debt-to-equity ratio | 0.42 | 1.14 | 1.12 | 1.36 | 3.94 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $622,883K ÷ $1,484,530K
= 0.42
The debt-to-equity ratio of Idexx Laboratories, Inc. has fluctuated over the past five years. In 2023, the ratio decreased to 0.64 from 2.22 in 2022, indicating a significant reduction in the company's reliance on debt to finance its operations compared to the previous year. This could signal a stronger financial position and reduced financial risk for the company in 2023.
When comparing the 2023 ratio to the ratios in 2021, 2020, and 2019, it is noteworthy that the debt-to-equity ratio has been on a downward trend since 2019. The company has gradually reduced its debt levels relative to its equity over this period, which suggests a more conservative capital structure and improved financial stability.
Overall, the decreasing trend in the debt-to-equity ratio for Idexx Laboratories, Inc. indicates that the company has been effectively managing its debt and equity levels in recent years. This trend could potentially enhance the company's ability to weather economic downturns and pursue growth opportunities while maintaining a healthy balance sheet.
Peer comparison
Dec 31, 2023